Literature DB >> 15703488

Transduction of the choroid plexus and ependyma in neonatal mouse brain by vesicular stomatitis virus glycoprotein-pseudotyped lentivirus and adeno-associated virus type 5 vectors.

Deborah J Watson1, Marco A Passini, John H Wolfe.   

Abstract

Evaluation of gene transfer into the developing mouse brain has shown that when adeno-associated virus serotype 1 (AAV1) or AAV2 vectors are injected into the cerebral lateral ventricles at birth, widespread parenchymal transduction occurs. Lentiviral vectors have not been tested by this route. In this study, we found that injection of lentiviral vectors pseudotyped with vesicular stomatitis virus glycoprotein (VSV-G) resulted in targeted transduction of the ependymal cells lining the ventricular system and the choroid plexus along the entire rostrocaudal axis of the brain, whereas a Mokola pseudotype transduced only a few cells after injection into the neonatal ventricle. In contrast, when lentiviral vectors pseudotyped with either VSV-G or Mokola glycoprotein are injected into the adult mouse brain, they transduce similar patterns of cells. An Ebola-Zaire-pseudotyped vector did not transduce any neonatal CNS cells, as was also the case for adult parenchymal injections. Long-term gene expression (12 months) occurred with a constitutively active mammalian promoter and a self-inactivating long terminal repeat (LTR), whereas the cytomegalovirus promoter in a vector with an intact LTR was expressed only in short-term experiments. We found that an AAV5 vector also targeted the ependymal and choroid plexus cells throughout the ventricular system. This vector exhibited limited penetration from the ventricle to other structures, which was significantly different from the previously reported patterns of transduction after intraventricular injection of AAV1 and AAV2 vectors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15703488     DOI: 10.1089/hum.2005.16.49

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  14 in total

Review 1.  ATP7A-related copper transport diseases-emerging concepts and future trends.

Authors:  Stephen G Kaler
Journal:  Nat Rev Neurol       Date:  2011-01       Impact factor: 42.937

Review 2.  Cell- and gene-based therapeutic approaches for neurological deficits in mucopolysaccharidoses.

Authors:  Dao Pan
Journal:  Curr Pharm Biotechnol       Date:  2011-06       Impact factor: 2.837

3.  ATP7A gene addition to the choroid plexus results in long-term rescue of the lethal copper transport defect in a Menkes disease mouse model.

Authors:  Anthony Donsante; Ling Yi; Patricia M Zerfas; Lauren R Brinster; Patricia Sullivan; David S Goldstein; Joseph Prohaska; Jose A Centeno; Elisabeth Rushing; Stephen G Kaler
Journal:  Mol Ther       Date:  2011-08-30       Impact factor: 11.454

4.  Intracranial delivery of CLN2 reduces brain pathology in a mouse model of classical late infantile neuronal ceroid lipofuscinosis.

Authors:  Marco A Passini; James C Dodge; Jie Bu; Wendy Yang; Qi Zhao; Dolan Sondhi; Neil R Hackett; Stephen M Kaminsky; Qinwen Mao; Lamya S Shihabuddin; Seng H Cheng; David E Sleat; Gregory R Stewart; Beverly L Davidson; Peter Lobel; Ronald G Crystal
Journal:  J Neurosci       Date:  2006-02-01       Impact factor: 6.167

5.  In Situ Hybridization for Detection of AAV-Mediated Gene Expression.

Authors:  Jacqueline E Hunter; Brittney L Gurda; Sea Young Yoon; Michael J Castle; John H Wolfe
Journal:  Methods Mol Biol       Date:  2019

6.  Viral transduction of the neonatal brain delivers controllable genetic mosaicism for visualising and manipulating neuronal circuits in vivo.

Authors:  Ji-Yoen Kim; Ryan T Ash; Carolina Ceballos-Diaz; Yona Levites; Todd E Golde; Stelios M Smirnakis; Joanna L Jankowsky
Journal:  Eur J Neurosci       Date:  2013-01-24       Impact factor: 3.386

7.  Survival advantage of neonatal CNS gene transfer for late infantile neuronal ceroid lipofuscinosis.

Authors:  Dolan Sondhi; Daniel A Peterson; Andrew M Edelstein; Katrina del Fierro; Neil R Hackett; Ronald G Crystal
Journal:  Exp Neurol       Date:  2008-04-30       Impact factor: 5.330

8.  Expanded repertoire of AAV vector serotypes mediate unique patterns of transduction in mouse brain.

Authors:  Cassia N Cearley; Luk H Vandenberghe; Michael K Parente; Erin R Carnish; James M Wilson; John H Wolfe
Journal:  Mol Ther       Date:  2008-08-19       Impact factor: 11.454

Review 9.  Adeno-associated virus (AAV) gene therapy for neurological disease.

Authors:  Marc S Weinberg; R Jude Samulski; Thomas J McCown
Journal:  Neuropharmacology       Date:  2012-03-17       Impact factor: 5.250

10.  Fetal Brain-directed AAV Gene Therapy Results in Rapid, Robust, and Persistent Transduction of Mouse Choroid Plexus Epithelia.

Authors:  Marie Reine Haddad; Anthony Donsante; Patricia Zerfas; Stephen G Kaler
Journal:  Mol Ther Nucleic Acids       Date:  2013-06-25       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.